Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Accounts Payables: 2019-2024

Historic Accounts Payables for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $18.5 million.

  • CureVac N.V's Accounts Payables rose 6.07% to $8.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $8.6 million, marking a year-over-year increase of 6.07%. This contributed to the annual value of $18.5 million for FY2024, which is 64.29% down from last year.
  • Latest data reveals that CureVac N.V reported Accounts Payables of $18.5 million as of FY2024, which was down 64.29% from $51.7 million recorded in FY2023.
  • CureVac N.V's Accounts Payables' 5-year high stood at $146.1 million during FY2021, with a 5-year trough of $18.5 million in FY2024.
  • Its 3-year average for Accounts Payables is $48.4 million, with a median of $51.7 million in 2023.
  • Its Accounts Payables has fluctuated over the past 5 years, first spiked by 465.03% in 2021, then plummeted by 64.29% in 2024.
  • Over the past 5 years, CureVac N.V's Accounts Payables (Yearly) stood at $25.9 million in 2020, then soared by 465.03% to $146.1 million in 2021, then slumped by 48.70% to $75.0 million in 2022, then plummeted by 31.05% to $51.7 million in 2023, then crashed by 64.29% to $18.5 million in 2024.